Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Esbriet
Biotech
PureTech's lung fibrosis drug slows decline in phase 2 trial
PureTech’s only internal drug program has slowed lung function decline in a phase 2 trial in idiopathic pulmonary fibrosis.
James Waldron
Dec 16, 2024 7:00am
BMS charts 2nd pulmonary fibrosis win with LPA1 antagonist
Sep 11, 2023 10:05am
A drug may already exist to counter heart risk in older men
Jul 14, 2022 2:00pm
Kadmon clinical POC data raise expectations for IPF drug
Feb 13, 2018 9:06am
Roche in part-sale of mixed bag lebrikizumab to Dermira
Aug 8, 2017 9:22am
FibroGen soars as IPF data paint pamrevlumab as a blockbuster
Aug 8, 2017 7:54am
